Northern Trust Corp Grows Position in Option Care Health, Inc. (NASDAQ:OPCH)

Northern Trust Corp raised its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 11.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,626,478 shares of the company's stock after purchasing an additional 278,158 shares during the quarter. Northern Trust Corp owned approximately 1.54% of Option Care Health worth $60,934,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Barclays PLC raised its stake in Option Care Health by 180.1% in the third quarter. Barclays PLC now owns 310,194 shares of the company's stock worth $9,708,000 after buying an additional 199,454 shares in the last quarter. Nordea Investment Management AB grew its holdings in shares of Option Care Health by 6.0% during the 4th quarter. Nordea Investment Management AB now owns 94,641 shares of the company's stock worth $2,165,000 after acquiring an additional 5,365 shares during the period. Harbor Capital Advisors Inc. raised its position in shares of Option Care Health by 2.7% in the 4th quarter. Harbor Capital Advisors Inc. now owns 213,155 shares of the company's stock worth $4,945,000 after acquiring an additional 5,595 shares in the last quarter. Graypoint LLC bought a new stake in shares of Option Care Health during the fourth quarter valued at approximately $1,161,000. Finally, Assenagon Asset Management S.A. grew its stake in Option Care Health by 128.2% in the fourth quarter. Assenagon Asset Management S.A. now owns 292,090 shares of the company's stock worth $6,776,000 after purchasing an additional 164,086 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

OPCH has been the topic of a number of recent research reports. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Barrington Research restated an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Wednesday, April 30th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JMP Securities restated a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $26.00 to $33.00 in a report on Monday, January 13th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $35.50.

Option Care Health Price Performance

Shares of NASDAQ:OPCH traded down $0.32 during midday trading on Monday, reaching $31.52. 478,993 shares of the company were exchanged, compared to its average volume of 1,838,851. The stock has a market cap of $5.16 billion, a PE ratio of 26.32, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The business's fifty day moving average is $33.24 and its two-hundred day moving average is $28.89. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business's revenue was up 16.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.26 earnings per share. As a group, analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Buying and Selling at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.